TRAIL/TRAIL Receptor System and Susceptibility to Multiple Sclerosis

• Carlos López-Gómez ,

  Contributed equally to this work with: Carlos López-Gómez, Óscar Fernández, Laura Leyva

  Affiliation Research Laboratory, Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya and Fundación IMABIS, Málaga, Spain

  ⨯
• Óscar Fernández ,

  Contributed equally to this work with: Carlos López-Gómez, Óscar Fernández, Laura Leyva

  Affiliation Department of Neurology, Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya and Fundación IMABIS, Málaga, Spain

  ⨯
• Juan Antonio García-León,

  Affiliation Research Laboratory, Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya and Fundación IMABIS, Málaga, Spain

  ⨯
• María Jesús Pinto-Medel,

  Affiliation Research Laboratory, Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya and Fundación IMABIS, Málaga, Spain

  ⨯
• Begoña Oliver-Martos,

  Affiliation Research Laboratory, Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya and Fundación IMABIS, Málaga, Spain

  ⨯
• Jesús Ortega-Pinazo,

  Affiliation Research Laboratory, Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya and Fundación IMABIS, Málaga, Spain

  ⨯
• Margarita Suardíaz,

  Affiliation Research Laboratory, Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya and Fundación IMABIS, Málaga, Spain

  ⨯
• Lucía García-Trujillo,

  Affiliation Department of Neurology, Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya and Fundación IMABIS, Málaga, Spain

  ⨯
• Cristina Guijarro-Castro,

  Affiliation Department of Neurology, University Hospital 12 de Octubre, Madrid, Spain

  ⨯
• Julián Benito-León,

  Affiliations Department of Neurology, University Hospital 12 de Octubre, Madrid, Spain, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Madrid, Spain, Department of Medicine, Complutense University, Madrid, Spain

  ⨯
• Isidro Prat,

  Affiliation Transfusion Center Blood Bank, Málaga, Spain

  ⨯
• Jezabel Varadé,

  Affiliation Department of Immunology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain

  ⨯
• Roberto Álvarez-Lafuente,

  Affiliation Department of Neurology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain

  ⨯
• Elena Urcelay,

  Affiliation Department of Immunology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain

  ⨯
• Laura Leyva

  Contributed equally to this work with: Carlos López-Gómez, Óscar Fernández, Laura Leyva

  * E-mail: laura.leyva.exts@juntadeandalucia.es

  Affiliation Research Laboratory, Clinical Neurosciences Institute, Hospital Regional Universitario Carlos Haya and Fundación IMABIS, Málaga, Spain

  ⨯